These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

467 related articles for article (PubMed ID: 20438984)

  • 21. [Management of bone and mineral metabolism disorders before the dialysis stage remains still perfectible. Data from the French Phosphorus and Calcium Survey Photo-Graphe].
    Jean G; Daugas É; Roth H; Drueke T; Bouchet JL; Hannedouche T; London G; Fouque D
    Nephrol Ther; 2017 Nov; 13(6):470-478. PubMed ID: 28843391
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adherence to Kidney Disease: Improving Global Outcomes Mineral and Bone Guidelines for Monitoring Biochemical Parameters.
    Roetker NS; Peng Y; Ashfaq A; Gilbertson DT; Wetmore JB
    Am J Nephrol; 2019; 49(3):225-232. PubMed ID: 30820015
    [TBL] [Abstract][Full Text] [Related]  

  • 23. KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD).
    Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group
    Kidney Int Suppl; 2009 Aug; (113):S1-130. PubMed ID: 19644521
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The new kidney disease: improving global outcomes (KDIGO) guidelines - expert clinical focus on bone and vascular calcification.
    London G; Coyne D; Hruska K; Malluche HH; Martin KJ
    Clin Nephrol; 2010 Dec; 74(6):423-32. PubMed ID: 21084045
    [TBL] [Abstract][Full Text] [Related]  

  • 25. KDIGO clinical practice guidelines for the diagnosis, evaluation, prevention, and treatment of mineral and bone disorders in chronic kidney disease.
    Matuszkiewicz-Rowińska J
    Pol Arch Med Wewn; 2010 Jul; 120(7-8):300-6. PubMed ID: 20693962
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Canadian Society of Nephrology commentary on the KDIGO clinical practice guideline for CKD evaluation and management.
    Akbari A; Clase CM; Acott P; Battistella M; Bello A; Feltmate P; Grill A; Karsanji M; Komenda P; Madore F; Manns BJ; Mahdavi S; Mustafa RA; Smyth A; Welcher ES
    Am J Kidney Dis; 2015 Feb; 65(2):177-205. PubMed ID: 25511161
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [CKD-MBD (Chronic Kidney Disease-Mineral and Bone Disorder). Paradigm shift in CKD-MBD guideline].
    Yokoyama K
    Clin Calcium; 2010 Jul; 20(7):1012-20. PubMed ID: 20585179
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Chronic kidney disease (CKD) and bone. Chronic kidney disease--mineral and bone disorder in predialysis patients].
    Inaguma D; Tatematsu M
    Clin Calcium; 2009 Apr; 19(4):493-9. PubMed ID: 19329827
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [CKD-MBD (chronic kidney disease-mineral and bone disorder). CKD-MBD: chronic kidney disease-mineral and bone disorder].
    Mizobuchi M; Aoshima Y; Akizawa T
    Clin Calcium; 2010 Jul; 20(7):995-1003. PubMed ID: 20585177
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Spanish Society of Nephrology recommendations for controlling mineral and bone disorder in chronic kidney disease patients (S.E.N.-M.B.D.). Introduction.
    Torregrosa JV; Bover J; Cannata Andía J
    Nefrologia; 2011; 31 Suppl 1():1-2. PubMed ID: 21468160
    [No Abstract]   [Full Text] [Related]  

  • 31. Mineral and bone disease pattern in elderly haemodialysis patients.
    Pelletier S; Roth H; Bouchet JL; Drueke T; London G; Fouque D;
    Nephrol Dial Transplant; 2010 Sep; 25(9):3062-70. PubMed ID: 20237058
    [TBL] [Abstract][Full Text] [Related]  

  • 32. KDIGO CKD-MBD Discussion forum: the Brazilian perspective.
    Moysés RM; Cancela AL; Gueiros JE; Barreto FC; Neves CL; Canziani ME; Oliveira RB; Jorgetti V; Carvalho AB
    J Bras Nefrol; 2010; 32(3):229-36. PubMed ID: 21103684
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CKD-MBD: comfort in the trough of the U.
    Cunningham J; Silver J
    Nephrol Dial Transplant; 2011 Jun; 26(6):1764-6. PubMed ID: 21551089
    [No Abstract]   [Full Text] [Related]  

  • 34. Association between Hemodialysis Patient Outcomes and Compliance with KDOQI and KDIGO Targets for Mineral and Bone Metabolism.
    Djukanović L; Dimković N; Marinković J; Djurić Ž; Knežević V; Lazarević T; Ljubenović S; Marković R; Rabrenović V
    Nephron; 2016; 132(3):168-74. PubMed ID: 26914677
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recommendations of the Spanish Society of Nephrology for the management of mineral and bone metabolism disorders in patients with chronic kidney disease: 2021 (SEN-MM).
    Torregrosa JV; Bover J; Rodríguez Portillo M; González Parra E; Dolores Arenas M; Caravaca F; González Casaus ML; Martín-Malo A; Navarro-González JF; Lorenzo V; Molina P; Rodríguez M; Cannata Andia J
    Nefrologia (Engl Ed); 2023 Jun; 43 Suppl 1():1-36. PubMed ID: 37202281
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Arteriosclerosis and vascular calcification in chronic kidney disease (CKD) patients].
    Masho Y; Shigematsu T
    Clin Calcium; 2007 Mar; 17(3):354-9. PubMed ID: 17339739
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Therapeutic interventions for chronic kidney disease-mineral and bone disorders: focus on mortality.
    Block GA
    Curr Opin Nephrol Hypertens; 2011 Jul; 20(4):376-81. PubMed ID: 21519253
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Treatment of CKD-MBD targeting the parathyroid gland].
    Isozaki Y; Komaba H
    Clin Calcium; 2016 Jun; 26(6):895-903. PubMed ID: 27230846
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adaptation and implementation of the "Kidney Disease: Improving Global Outcomes (KDIGO)" guidelines for evaluation and management of mineral and bone disorders in chronic kidney disease for practice in the Middle East countries.
    Al Rukhaimi M; Al Sahow A; Boobes Y; Goldsmith D; Khabouth J; El Baz T; Mahmoud H; Ganji MR; Shaheen FA;
    Saudi J Kidney Dis Transpl; 2014 Jan; 25(1):133-48. PubMed ID: 24434398
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Treatment for CKD-MBD(Chronic Kidney Disease-Mineral and Bone Disorder)].
    Iwashita Y; Iwashita Y; Ito T; Shigematsu T
    Clin Calcium; 2016 Feb; 26(2):259-67. PubMed ID: 26813506
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.